Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Gerdts

Showing results (221-230 of 262) with videos related to

Pageof 27
Sort By:
Journal of the American College of Cardiology|March 1, 2005
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) studyKristian Wachtell, Mika Lehto, Eva Gerdts, et al.
European Heart Journal. Cardiovascular Imaging|August 6, 2016
Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implicationsEdda Bahlmann, Dana Cramariuc, Jan Minners, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|March 26, 2024
Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug NonadherenceArleen Aune, Annabel Ohldieck, Lene V Halvorsen, et al.
American Heart Journal|February 9, 2002
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint ReductionKristian Wachtell, Vittorio Palmieri, Michael H Olsen, et al.
American Journal of Hypertension|June 15, 2012
Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE studyAnders M Greve, Michael H Olsen, Jonathan N Bella, et al.
Heart (British Cardiac Society)|May 1, 2014
Adjusting parameters of aortic valve stenosis severity by body sizeJan Minners, Christa Gohlke-Baerwolf, Beat A Kaufmann, et al.
BMC Neurology|July 20, 2013
The Norwegian Stroke in the Young Study (NOR-SYS): rationale and designAnnette Fromm, Lars Thomassen, Halvor Naess, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2023
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-AnalysisZeinab Bidel, Milad Nazarzadeh, Dexter Canoy, et al.
Journal of the American College of Cardiology|March 1, 2005
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) studyKristian Wachtell, Björn Hornestam, Mika Lehto, et al.
Heart (British Cardiac Society)|September 14, 2014
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EFNikolaus Jander, Willibald Hochholzer, Beat A Kaufmann, et al.
Pageof 27

Showing results (221-230 of 262) with videos related to

Sort By:
Pageof 27
Journal of the American College of Cardiology|March 1, 2005
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) studyKristian Wachtell, Mika Lehto, Eva Gerdts, et al.
European Heart Journal. Cardiovascular Imaging|August 6, 2016
Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implicationsEdda Bahlmann, Dana Cramariuc, Jan Minners, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|March 26, 2024
Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug NonadherenceArleen Aune, Annabel Ohldieck, Lene V Halvorsen, et al.
American Heart Journal|February 9, 2002
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint ReductionKristian Wachtell, Vittorio Palmieri, Michael H Olsen, et al.
American Journal of Hypertension|June 15, 2012
Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE studyAnders M Greve, Michael H Olsen, Jonathan N Bella, et al.
Heart (British Cardiac Society)|May 1, 2014
Adjusting parameters of aortic valve stenosis severity by body sizeJan Minners, Christa Gohlke-Baerwolf, Beat A Kaufmann, et al.
BMC Neurology|July 20, 2013
The Norwegian Stroke in the Young Study (NOR-SYS): rationale and designAnnette Fromm, Lars Thomassen, Halvor Naess, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2023
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-AnalysisZeinab Bidel, Milad Nazarzadeh, Dexter Canoy, et al.
Journal of the American College of Cardiology|March 1, 2005
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) studyKristian Wachtell, Björn Hornestam, Mika Lehto, et al.
Heart (British Cardiac Society)|September 14, 2014
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EFNikolaus Jander, Willibald Hochholzer, Beat A Kaufmann, et al.
Pageof 27